Literature DB >> 2390673

Characterization of the adenosine receptor in porcine coronary arteries.

A D King1, M Milavec-Krizman, E Müller-Schweinitzer.   

Abstract

1. Relaxant responses of ring preparations from porcine ventricular coronary arteries to adenosine and various stable adenosine analogues were investigated in vitro. 2. The adenosine analogues did not produce contraction but elicited almost complete relaxation of coronary arteries preconstricted with 3 microM prostaglandin F2 alpha (PGF2 alpha), even after removal of the endothelium. 3. The order of potency, was 5'-N-ethylcarboxamide-adenosine (NECA) greater than 2-(2-phenylethylamino)5'-N-ethylcarboxamide-adenosine (2-PEA-NECA) greater than 2-phenylamino-adenosine (CV-1808) greater than N6-[R(-)-1-phenyl-2-propyl]adenosine (R-PIA) greater than N6-[S(+)-1-phenyl-2-propyl]adenosine (S-PIA) greater than N6-cyclopentyl-adenosine (CPA) greater than adenosine greater than ATP offDP which suggested the presence of adenosine A2-receptor subtypes. 4. There was an excellent correlation between the calculated pD2 values on coronary arteries and the pKD values at adenosine A2 binding sites, whereas no correlation was obtained when the pD2 values were compared to the pKD values at adenosine A1-binding sites on membranes from porcine striata. 5. The relaxant effects of adenosine and its analogues were competitively antagonized by 8-(p-sulphophenyl)-theophylline (8-SPT), producing pA2 values similar to the respective pKD value of the antagonist at adenosine A2 binding sites. 6. It is suggested that the porcine coronary artery possesses adenosine A2 receptors which seem to be similar to the adenosine A2 binding site in pig striatum, whereas no evidence was obtained for the presence of adenosine A1 receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390673      PMCID: PMC1917790          DOI: 10.1111/j.1476-5381.1990.tb15833.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

2.  Evidence suggesting an Ra-type adenosine receptor in bovine coronary arteries.

Authors:  S J Mustafa; A O Askar
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

Review 3.  Therapeutic potential for new selective adenosine receptor ligands and metabolism inhibitors.

Authors:  C J Bowmer; M S Yates
Journal:  Trends Pharmacol Sci       Date:  1989-09       Impact factor: 14.819

4.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

5.  Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.

Authors:  R F Bruns; G H Lu; T A Pugsley
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets.

Authors:  D S Houston; J T Shepherd; P M Vanhoutte
Journal:  Am J Physiol       Date:  1985-03

8.  Evidence for an A2 adenosine receptor in human coronary arteries.

Authors:  M V Ramagopal; R W Chitwood; S J Mustafa
Journal:  Eur J Pharmacol       Date:  1988-07-14       Impact factor: 4.432

9.  Effects of adenosine and calcium entry blockers on 3,4-diaminopyridine-induced rhythmic contractions in dog coronary artery.

Authors:  M Nakazawa; S J Mustafa
Journal:  Eur J Pharmacol       Date:  1988-05-10       Impact factor: 4.432

10.  Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors.

Authors:  S Kusachi; R D Thompson; R A Olsson
Journal:  J Pharmacol Exp Ther       Date:  1983-11       Impact factor: 4.030

View more
  12 in total

1.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

2.  Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypes.

Authors:  Jianjie Wang; Stevan P Whitt; Leona J Rubin; Virginia H Huxley
Journal:  Microcirculation       Date:  2005-06       Impact factor: 2.628

3.  Evidence for the presence of A1 and A2 adenosine receptors in the ventral aorta of the dogfish shark, Squalus acanthias.

Authors:  D H Evans
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  Interactions between responses mediated by activation of adenosine A2 receptors and alpha 1-adrenoceptors in the rabbit isolated aorta.

Authors:  H L Wiener; G P Thalody; S Maayani
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

6.  The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetized pigs.

Authors:  C L Wainwright; J R Parratt; H Van Belle
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

7.  Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart.

Authors:  K S Erga; C N Seubert; H X Liang; L Wu; J C Shryock; L Belardinelli
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 8.  Diversity in mechanisms of endothelium-dependent vasodilation in health and disease.

Authors:  Matthew J Durand; David D Gutterman
Journal:  Microcirculation       Date:  2013-04       Impact factor: 2.628

9.  Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues.

Authors:  A Conti; A Monopoli; M Gamba; P A Borea; E Ongini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

10.  Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia.

Authors:  B A Finegan; G D Lopaschuk; M Gandhi; A S Clanachan
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.